Iridex (IRIX) Cash from Operations Growth (1y) (2012 - 2026)
Iridex (IRIX) Cash from Operations Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | 21.54% |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 13.50% |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 1.78% |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 14.62% |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 124.64% |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | -11.16% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 78.72% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -0.23% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | -12.60% |
| 10 | Iridex | 13.34 Mn | 8.66 Mn | 4.30 Mn | 143.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -16.19% |
| Jan 3, 2026 | 147.58% |
| Sep 27, 2025 | 62.32% |
| Jun 28, 2025 | 70.06% |
| Mar 29, 2025 | 30.28% |
| Dec 28, 2024 | -26.46% |
| Sep 28, 2024 | -72.45% |
| Jun 29, 2024 | -16.21% |
| Mar 30, 2024 | 42.03% |
| Dec 30, 2023 | 38.43% |
| Sep 30, 2023 | 15.38% |
| Jul 1, 2023 | 55.60% |
| Apr 1, 2023 | 12.60% |
| Dec 31, 2022 | -114.14% |
| Apr 2, 2022 | -127.50% |
| Apr 3, 2021 | 914.18% |
| Sep 26, 2020 | 116.00% |
| Jun 27, 2020 | -45.60% |
| Mar 28, 2020 | 61.73% |
| Dec 28, 2019 | 90.78% |